Staying Ahead of the Curve: PULSE equips Pharma Professionals with Revised Schedule M Knowledge

The Indian pharmaceutical industry is undergoing a transformative shift. The implementation of the revised Schedule M signifies a commitment to stringent Good Manufacturing Practices (GMP) that align with international standards. This ensures not only the quality and safety of medications produced in India but also strengthens the country's position in the global pharma market.

Understanding the Revised Schedule M: A Crucial Step

The revised Schedule M lays down a comprehensive set of guidelines for pharmaceutical manufacturing in India. These updated regulations cover various aspects, including:

• Facility and Equipment: Requirements for infrastructure, equipment maintenance, and calibration.
• Quality Control: Enhanced procedures for testing and ensuring product quality.
• Documentation: Stricter regulations for data integrity and record-keeping.
• Personnel Training: Emphasis on upskilling personnel to comply with the new standards.

PULSE: A Collaborative Effort for Upgrading Pharmaceutical Knowledge

Recognizing the importance of adapting to these changes, the Federation of Pharma Entrepreneurs (FOPE) (FOPE) and PharmaState.Academy? have joined forces to launch a commendable initiative called PULSE. This program offers a series of 25 online live learning sessions specifically designed to equip pharmaceutical professionals with a thorough understanding of the revised Schedule M.

Why Attend These Sessions?

• Stay Compliant, Avoid Delays: A comprehensive understanding of the revised Schedule M is crucial for ensuring your manufacturing practices comply with regulations. This reduces the risk of regulatory hurdles and production delays.
• Embrace Best Practices: The revised Schedule M aligns with global GMP standards. By participating in PULSE, you'll gain insights into international best practices, enhancing your overall manufacturing capabilities.
• Future-proof Your Career: The pharmaceutical industry is constantly evolving. Equipping yourself with the latest knowledge will make you a more valuable asset and position you for future success.

A Program Designed for Accessibility

PULSE recognizes the needs of professionals across the industry. They offer a flexible format with the first two sessions being free to attend. Attending all the sessions rewards you with a special certificate, a valuable addition to your professional qualifications.

Standing Strong Together

This initiative is further bolstered by the valuable contributions of our Knowledge Partner, Trillyum Consulting , whose expertise ensures the program's content is current and insightful. Additionally, we'd like to acknowledge the generous support of our Session Sponsor, Next Wave (India) , and our esteemed Media Partner, Express Pharma , who will help spread awareness about this crucial program.

A Network of Support for the Industry

We are grateful for the backing of our esteemed Supporting Associations: Himachal Drug Manufacturers Association, Rajasthan Pharmaceutical Manufacturers Association, Federation of MP Chambers of Commerce & Industry, Karnataka Drugs & Pharmaceuticals Manufacturer's Association, CiPi, Laghu Udyog Bharati - India , The Pharmaceutical Manufacturer's Association of Tamil Nadu, and Drug Manufacturers Association. Their support signifies the industry's collective commitment to knowledge sharing and continuous improvement.

Ready to Take the Next Step?

Don't miss this opportunity to stay ahead of the curve and elevate your knowledge of the revised Schedule M. To register for the PULSE program and secure your spot in these informative sessions, visit the official registration link:

Together, let's ensure the Indian pharmaceutical industry thrives under the new regulatory landscape